Skip to main content
. Author manuscript; available in PMC: 2016 Jul 5.
Published in final edited form as: Int J Pharm. 2015 Apr 15;488(0):33–43. doi: 10.1016/j.ijpharm.2015.04.031

Figure 4.

Figure 4

In-vivo absorption profiles of (A) plain SOD administered either intravenously (IV) or intratracheally (IT), (B) plain fasudil via IT or IV, (C) plain combination of SOD+fasudil IT, (D) unmodified liposomes containing both drugs IT, and (E) CAR-liposomes containing both drugs IT. Doses of SOD and fasudil were 5 and 6 mg/kg, respectively. Data represent mean ± standard deviation (n=3).